Skip to main
OFIX
OFIX logo

Orthofix International (OFIX) Stock Forecast & Price Target

Orthofix International (OFIX) Analyst Ratings

Based on 13 analyst ratings
Buy
Strong Buy 62%
Buy 8%
Hold 31%
Sell 0%
Strong Sell 0%

Bulls say

Orthofix Medical Inc. has raised its long-term net sales compound annual growth rate (CAGR) target to 6.5%-7.5%, reflecting continued strong growth expectations in its key segments. The company reported adjusted EBITDA of $23.9 million, a year-over-year increase of $4.3 million, demonstrating margin expansion and exceeding market consensus. Furthermore, significant growth was observed in both Spine Fixation and Bone Growth Therapies, with respective year-over-year increases of 12% and 9%, indicating robust demand and a strong market position in the orthopedic and spine solutions sector.

Bears say

Orthofix Medical Inc. has faced significant challenges following the discontinuation of its M6-C and M6-L artificial disc product lines, which were projected to generate $23.4 million in sales for 2024, highlighting a strategic shift away from certain product offerings in response to declining demand. The company’s long-term sales CAGR expectations have been adjusted downward, indicating a weaker growth trajectory as profitability remains pressured by ongoing competitive threats and integration risks associated with the merger with SeaSpine. Moreover, regulatory and reimbursement rate uncertainties further cloud the outlook, potentially hindering earnings and overall financial stability amid a complex and evolving healthcare landscape.

Orthofix International (OFIX) has been analyzed by 13 analysts, with a consensus rating of Buy. 62% of analysts recommend a Strong Buy, 8% recommend Buy, 31% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Orthofix International and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Orthofix International (OFIX) Forecast

Analysts have given Orthofix International (OFIX) a Buy based on their latest research and market trends.

According to 13 analysts, Orthofix International (OFIX) has a Buy consensus rating as of Jul 24, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $35.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $35.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Orthofix International (OFIX)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.